Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)

Clinical trial NCT02543255 · COMPLETED

Trial details

NCT number: NCT02543255
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2016-09-01
Primary completion: 2021-05-27
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.